Similar findings were also obtained upon the treatment of NETs with a neutralizing antibody against IL-17A (Figure 3A–C), underlining the pro-inflammatory dynamic of asthma NETs in the fibrotic aspect of HELFs. Here, IL17A is linked to asthma.